What We're Reading: Page 136
Industry reads hand-picked by our editors
Jan 11, 2022
Jan 10, 2022
Jan 07, 2022
Jan 06, 2022
-
STAT
Top hospitals aren’t offering Alzheimer's drug Aduhelm
-
TechCrunch
"How can you understand life if you don’t look at it live?" — Eikon Therapeutics rakes in $518M
-
San Francisco Business Times
Clinical trial sets stage for biotech's goal to beat a rare disease
-
Axios
IBM tries to sell Watson Health again
Jan 05, 2022
Jan 04, 2022
-
The Wall Street Journal
The Elizabeth Holmes Verdict: Theranos Founder Is Guilty on Four of 11 Charges in Fraud Trial
-
The Washington Post
India's Corbevax vaccine was developed at Texas Children's Hospital. It expects nothing in return.
-
BioCentury
Former FDA Commissioner Crawford dead at 83
-
Reuters
Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill
Jan 03, 2022
-
Nasdaq
Here’s What Happened to Biotech This Year
-
The New York Times
Alzheimer's Drug Aduhelm Faces Crucial Medicare Decision
-
Associated Press
New York jury holds drugmaker Teva liable in opioid crisis
-
Reuters
Samsung BioLogics says report on Biogen deal talks untrue
-
POLITICO
Biden officials now fear booster programs will limit global vaccine supply
-
STAT
BridgeBio’s heart drug misses primary goal in pivotal study
Previous
